4.220 s

+0.060 (+1.44%)
Range 4.120 - 4.278   (3.83%)
Open -
Previous Close 4.160
Bid Price 1.030
Bid Volume 11
Ask Price 1.040
Ask Volume 12
Volume 9,178
Value -
Remark s
Delayed prices. Updated at 29 Mar 2024 03:44.
Data powered by
View All Events

About NEUROMETRIX INC

NeuroMetrix, Inc. (NeuroMetrix) is a medical device company focused on the diagnosis and treatment of the neurological complications of diabetes. The Company is in the position to address these unmet needs through the development of medical devices. The Company intends to advance its objectives in the diabetic neuropathy market include: Driving Commercial Adoption of Products for Diabetic Neuropathy in the United States. The Company develops and market neurodiagnostic systems, which typically consists of a medical device plus single patient-use biosensors or electrodes.The Company�s NC-stat DPNCheck consists of an electronic hand-held device and a single patient use biosensor. More than 1.7 million patient studies have been performed using the Company's NC-stat technology and there have been approximately 6.3 million nerve tests, including nearly 700,000 sural nerve tests.

There are 1 follower

Followers
0